Ablacon: Ablacon Announces Closing of a $10 Million Venture Debt Facility and $2 Million Equity Investment from Western Technology Investment; Josef Koblish and Melissa Kong to Join the Company
This financing will help fund Ablacon's first multicenter randomized clinical trial for Ablamap, an advanced mapping system for patients with atrial fibrillation.
Read full article »
Ablacon is a Colorado-based AI firm that designs and develops an atrial fibrillation system to analyze and visualize electrographic flow within the cardiac chambers.
Read more